期刊文献+

Anti-tumor Action and Clinical Application of Proteasome Inhibitor 被引量:2

Anti-tumor Action and Clinical Application of Proteasome Inhibitor
下载PDF
导出
摘要 Ubiquitin-proteasome pathway mediates the degradation of cell protein, and cell cycle, gene translation and expression, antigen presentation and inflammatory development. Proteasome inhibitor can inhibit growth and proliferation of tumor cell, induce apoptosis and reverse multipledrug resistance of tumor cell, increase the sensitivity of other chemotherapeutic drugs and radiotherapy, and is a novel class of potent anti-tumor agents. Ubiquitin-proteasome pathway mediates the degradation of cell protein, and cell cycle, gene translation and expression, antigen presentation and inflammatory development. Proteasome inhibitor can inhibit growth and proliferation of tumor cell, induce apoptosis and reverse multipledrug resistance of tumor cell, increase the sensitivity of other chemotherapeutic drugs and radiotherapy, and is a novel class of potent anti-tumor agents.
出处 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 2008年第2期77-84,共8页 中国癌症研究(英文版)
基金 the National Outstanding Youth Scientists Foundation of china(No.30225038) and the Youth and Middle-Age Scientists Science and Research Found of the Affiliated Hospital,Wuhan University of Science and Technology.
关键词 Proteasome inhibitor Ubiquitin-proteasome pathway TUMOR Proteasome inhibitor Ubiquitin-proteasome pathway Tumor
  • 相关文献

参考文献43

  • 1Voorhees PM, Dees EC, O'Neil B, et al. The proteasome as a target for cancer therapy[J]. Clin Cancer Res 2003; 9:6316-25.
  • 2Tao GZ, Rott LS, Lowe AW, et al. Hyposmotic stress induces cell growth arrest via proteasome activation and cyclin/cyclin-dependent kinase degradation[J]. J Biol Chem 2002; 277:19295-303.
  • 3Xu J, Attisano L. Mutations in the tumor suppressors Smad2 and Smad4 inactivate transforming growth factor beta signaling by targeting smads to ubiquitin-proteasome pathway[J]. Proc Natl Acad Sci USA 2000; 97: 4820-5.
  • 4Ogiso Y, Tomida A, Kim HD, et al. Glucose starvation and Hypoxia induce nuclear accumulation of proteasome in cancer cells[J]. Biochem Biophys Res Commun 1999; 258: 448-52.
  • 5Aghajanian C, Soigent S, Dizon DS, et al. A phase Ⅰ trial of the novel proteasome inhibitor PS341 in advanced solid tumor malignancies[J]. Clin Cancer Res 2002; 8: 2505-11.
  • 6Sakata N, Dixon JL. Ubiquitin-proteasome-dependent degradation of apolipoprotein B100 in vitro[J]. Biochem Biophys Acta 1999; 1437: 71-9.
  • 7Koguchi Y, Kohno J, Nishio M, et al. Tmc-95A, B, C, and D, novel proteasome inhibitors produced by Apiospora montagnei Sacc. TC1093. Taxonomy, production, isolation, and biological activities[J]. J Antibiot 2000; 53:105-9.
  • 8Kazi A, Daniel KG, Smith DM, et al. Inhibition of proteasome activity, a novel mechanism associated with the tumor cell apoptosis-inducing ability of genistein[J]. Biochem Pharmacol 2003; 66: 965-76.
  • 9Adams J. Development of the proteasome inhibitor PS-341[J]. Oncologist 2002; 7: 9-16.
  • 10Leblanc R, Catley LP, Hideshima T, et al. Proteasome inhibitor PS-341 inhibits human myeloma cell growth in vivo and prolongs survival in a murine model[J]. Cancer Res 2002; 62: 4996-5000.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部